S

Subsense

Develops noninvasive nanotech BCI devices

Large Animal Neuroscience Lead

Biomedical Engineering & Medical DevicesUpdated on Nov 7
Full-timeMountain View, CA, USA

About the Job

Requirements

  • A PhD in neuroscience, neuroengineering, biomedical engineering, or a related field; alternatively, an MD, DVM, or other suitable advanced degree with substantial relevant research experience.
  • A track record of independently designing and executing in-vivo neuroscience studies, with substantial hands-on experience in pigs and other large animals.
  • Practical experience with large-animal neurophysiology, stereotactic procedures, and neural recording or stimulation, including confidence troubleshooting during live experiments.
  • Strong experimental-design and quantitative-analysis skills, including appropriate controls, artifact identification, and interpretation of electrophysiological data.
  • Experience managing CROs or comparable external research partners, including study planning, execution oversight, and evaluation of deliverables.
  • Demonstrated ability to lead and develop a small research team while remaining actively involved in experiments.
  • Experience working with veterinary teams and institutional animal-care and use processes, with a strong commitment to animal welfare and data integrity.
  • Ability to collaborate across neuroscience, nanoscience, and engineering and deliver well-documented results in a fast-paced, early-stage environment.
  • U.S.-based, with the ability to work on-site at study facilities and travel to CRO and partner sites as needed.
  • Clear written and spoken English, with the ability to communicate methods, results, and limitations to technical and nontechnical audiences.

Responsibilities

  • Design and execute acute, non-GLP pig neuroscience studies, defining controls, endpoints, and success criteria that separate nanoparticle delivery, activation, and neural response.
  • Work hands-on in the operating room on stereotactic targeting, experimental instrumentation, stimulation, and electrophysiological recordings alongside veterinary and surgical teams.
  • Lead a 3–4-person group of scientists and research staff, setting priorities, coordinating study days, and providing practical training, mentorship, and performance feedback.
  • Select and manage contract research organizations and academic partners, owning study scopes, protocols, budgets, timelines, on-site execution, and data quality.
  • Translate rodent methods into large-animal workflows; work with hardware engineers on prototype requirements, positioning, calibration, synchronization, and troubleshooting.
  • Establish reliable neural readouts and analysis workflows, distinguishing true biological responses from stimulation artifacts and physiological confounds.
  • Coordinate animal-use protocols, training, humane endpoints, and study documentation with institutional animal care and use committees and veterinary teams.
  • Connect physiology with imaging, particle-localization measurements, and tissue analysis to assess target engagement and acute tissue effects.
  • Deliver clear study reports and reproducible datasets that support technical decisions, development milestones, and investor diligence.

Desired Qualifications

  • Experience with intranasal or nose-to-brain delivery, nanoparticle biodistribution, or quantitative tissue-localization methods.
  • Experience with deep brain stimulation, movement-disorder neuroscience, or other neuromodulation technologies, including optical or magnetic approaches.
  • Experience with MRI/CT-guided targeting, histology, or electrophysiology analysis in Python or MATLAB.
  • Experience translating rodent methods or neurotechnology prototypes to large animals, or connecting non-GLP feasibility work to later regulated preclinical development.

About the Company

Subsense

Develops noninvasive nanotech BCI devices

Subsense develops nanotechnology-based noninvasive brain-computer interfaces and medical devices aimed at treating neurodegenerative diseases. Its products are designed for daily, seamless use in healthcare, combining brain signal interfaces with nanotech to aid patients and clinicians. The company works with academic experts from ETH Zurich and Stanford to guide research and development, and plans to sell or license its BCI devices in Europe and the USA. Compared with competitors, Subsense emphasizes noninvasive, nano-scale interfaces and strong collaborations to translate research into market-ready medical devices. The overarching goal is to improve quality of life for individuals with neurodegenerative conditions by delivering practical, clinician-friendly BCI solutions.

Company size
11-50
Company stage
Early VC
Total funding
$27M
Headquarters
Palo Alto, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Subsense

See more jobs